Growing investments in mRNA vaccine and therapeutic platforms, along with regulatory acceleration, are fueling steady global demand for high-purity raw materials.
Austin, Nov. 04, 2025 (GLOBE NEWSWIRE) — mRNA Synthesis Raw Materials Market Size & Growth Analysis
According to SNS Insider, the global mRNA synthesis raw material market was valued at USD 1.70 billion in 2024 and is projected to reach USD 2.67 billion by 2032, at a compound annual growth rate (CAGR) of 5.81% during the forecast period 2025-2032. The US led the segment with USD 0.57 billion in 2024 and is expected to reach USD 0.81 billion by 2032, driven by investments in mRNA vaccine and therapeutics, technological advancements, and ease of regulatory processes.
The surge in demand for mRNA-based vaccines and treatments for cancer, infectious diseases, and rare genetic disorders has driven the global need for high-purity raw materials, including IVT enzymes, capping reagents, nucleoside triphosphates, and modified nucleotides. The success of mRNA COVID-19 vaccines has led to significant investments by pharmaceutical and biotech companies, creating long-term growth opportunities.
Get free Sample Report of mRNA Synthesis Raw Materials Market: https://www.snsinsider.com/sample-request/7609
mRNA Synthesis Raw Materials Market Overview
The mRNA synthesis raw material market is the basis of modern mRNA-based therapeutics and vaccines. Large-scale developer companies, such as Moderna, BioNTech, and CureVac, are investing heavily in the research and development of raw materials as well as manufacturing facilities. Government funding, public-private partnerships, and easy regulatory approvals are strengthening the mRNA manufacturing infrastructure, which is driving market growth. Efforts by regulatory agencies are helping in faster approvals and standardization of the industry.
Major Players in the mRNA Synthesis Raw Materials Market Include:
mRNA Synthesis Raw Materials Market Segment Insights
By Type
In 2024, the nucleotides segment accounted for the largest revenue share in the global mRNA synthesis raw materials market at 36.9% of total revenue as nucleotides, such as ATP, GTP, CTP, and UTP, are essential to the in vitro transcription (IVT) process, which is the cornerstone of mRNA synthesis. The capping agents segment is predicted to expand at the highest growth rate due to heightened emphasis on improving mRNA stability and translational efficiency.
By Application
The vaccine production segment retained the maximum revenue share of 82.3% in 2024, owing to global immunization drives and pandemic preparedness efforts. The therapeutics production segment is growing at the maximum rate owing to a growing pipeline of mRNA-based therapeutics for cancer, cystic fibrosis, and genetic disease treatment.
By End-Use
Pharmaceutical and biopharmaceutical companies dominated the end-use segment with a 48.5% market revenue contribution in 2024. The growth is driven by their in-house large-scale production facility and investments by market leaders, such as Sanofi, BioNTech, and Moderna, in the development of the mRNA platform. The market for Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) is growing at the fastest rate as biotech startups and mid-sized businesses are outsourcing mRNA development on a large scale in order to use the expertise and infrastructure of CROs.
Need Any Customization Research on mRNA Synthesis Raw Materials Market, Enquire Now: https://www.snsinsider.com/enquiry/7609
Regional Analysis:
North America was the biggest mRNA synthesis raw materials market in 2024, led by its established biotechnology infrastructure, high R&D spending, and presence of industry heavyweights, such as Moderna and Thermo Fisher Scientific.
Asia Pacific is the fastest-growing region in the market, fueled by rising vaccine manufacturing capacity, expanding clinical trials, and encouraging government patronage for biotech localization.
Recent Developments in the mRNA Synthesis Raw Materials Market
Exclusive Sections of the Report (The USPs):
Buy the mRNA Synthesis Raw Materials Market Report Now: https://www.snsinsider.com/checkout/7609
mRNA Synthesis Raw Materials Market Report Scope
Access Complete Report Details of mRNA Synthesis Raw Materials Market Analysis & Outlook: https://www.snsinsider.com/reports/mrna-synthesis-raw-materials-market-7609
[For more information or need any customization research mail us at [email protected]]
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
